Home » Stocks » AVGR

Avinger, Inc. (AVGR)

Stock Price: $0.904 USD -0.106 (-10.50%)
Updated May 13, 2021 2:22 PM EDT - Market open
Market Cap 98.21M
Revenue (ttm) 9.06M
Net Income (ttm) -22.15M
Shares Out 91.44M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $0.904
Previous Close $1.010
Change ($) -0.106
Change (%) -10.50%
Day's Open 1.020
Day's Range 0.881 - 1.040
Day's Volume 4,195,059
52-Week Range 0.214 - 2.670

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medica...

6 days ago - Accesswire

Penny stocks to buy according to top Wall Street analysts The post 3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383% appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other stocks mentioned: CASI, MARK
1 week ago - PennyStocks

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

2 weeks ago - Accesswire

List Of Penny Stocks To Watch Right Now The post Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other stocks mentioned: GTBP, SENS
3 weeks ago - PennyStocks

REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

3 weeks ago - Accesswire

REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

4 weeks ago - Accesswire

REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

1 month ago - Accesswire

It's been reported that AVGR stock is popular among Robinhood traders. That's fine, but it's more important to see the company's potential.

1 month ago - InvestorPlace

Avinger (NASDAQ:AVGR) reported Q4 results on Thursday afternoon. Quarterly Results Earnings per share were up 87.93% over the past year to ($0.07), which missed the estimate of ($0.06).

2 months ago - Benzinga

19% Sequential Increase in Total Revenue Tigereye™ Drives 38% Sequential Growth in Image-Guided CTO Revenue REDWOOD CITY, CA / ACCESSWIRE / March 11, 2021 / Avinger, Inc. (NASDAQ: AVGR), a commercial-st...

2 months ago - Accesswire

REDWOOD CITY, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avinger, Inc. (Nasdaq: AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, ...

2 months ago - GlobeNewsWire

Avinger (NASDAQ:AVGR) announces its next round of earnings this Thursday, March 11. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

2 months ago - Benzinga

REDWOOD CITY, CA / ACCESSWIRE / March 2, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for di...

2 months ago - Accesswire

Avinger (AVGR) stock is on the rise Thursday despite there being no new news from the company but chatter about a patent on social media. The post AVGR Stock: The Social Media Buzz That Has Avinger Shar...

2 months ago - InvestorPlace

19 New U.S. and International Patents Issued and Allowed in 2020 REDWOOD CITY, CA / ACCESSWIRE / January 19, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the f...

3 months ago - Accesswire

Avinger (AVGR) stock is taking off on Friday after announcing the full commercial release of its Tigereye medical device. The post AVGR Stock: 11 Things to Know About Avinger as Shares Rocket Higher app...

3 months ago - InvestorPlace

REDWOOD CITY, CA / ACCESSWIRE / January 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f...

3 months ago - Accesswire

Avinger (AVGR) is seeing a massive boost to its stock on Friday after being listed as a hot penny stock to buy on Robinhood. The post AVGR Stock: 6 Things to Know About ‘Robinhood's Hot Penny Stock to B...

4 months ago - InvestorPlace

REDWOOD CITY, CA / ACCESSWIRE / January 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis an...

4 months ago - Accesswire

REDWOOD CITY, CA / ACCESSWIRE / December 23, 2020 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis ...

4 months ago - Accesswire

Avinger's (AVGR) CEO Jeff Soinski on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Avinger (AVGR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

6 months ago - Zacks Investment Research

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

7 months ago - Zacks Investment Research

Avinger (AVGR) news for Friday concerning approval from the FDA for one of its medical devices has AVGR stock on the move. The post Avinger News: AVGR Stock Down 8% Following FDA Approval appeared first...

8 months ago - InvestorPlace

Avinger's (AVGR) CEO Jeff Soinski on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Inside the top-ranked stocks that have been exhibiting rising price-to-earnings ratios.

Other stocks mentioned: BLRX, PTI, VCNX, VIVE
10 months ago - Zacks Investment Research

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Other stocks mentioned: CSV, MOGO, PTE, TNK
11 months ago - Zacks Investment Research

There are pockets of the stock market that look far too overvalued to ignore, and our deep learning algorithms paired with our Artificial Intelligence (“AI”) technology has identified the top short targ...

Other stocks mentioned: GHSI, KAR
11 months ago - Forbes

Avinger (AVGR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

11 months ago - Zacks Investment Research

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Forget undervalued stocks, play these top-ranked stocks with rising P/E.

Other stocks mentioned: FEYE, JAKK, PTI, WATT
1 year ago - Zacks Investment Research

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Other stocks mentioned: ACRX, GNCA, GOSS, VFF
1 year ago - Zacks Investment Research

Bet on these top-ranked stocks with rising P/E for outsized gains.

Other stocks mentioned: ALXN, CYBR, ONVO, QLYS
1 year ago - Zacks Investment Research

Avinger, Inc. (AVGR) CEO Jeffrey Soinski on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Other stocks mentioned: ALXN, CHKP, NOW, TRIP
1 year ago - Zacks Investment Research

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

1 year ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for October 24th

Other stocks mentioned: ACM, BC, BOOT
1 year ago - Zacks Investment Research

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Other stocks mentioned: SPSC, SWKS, TUES, VAR
1 year ago - Zacks Investment Research

REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an...

1 year ago - GlobeNewsWire

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of a...

1 year ago - GlobeNewsWire

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends ...

1 year ago - GlobeNewsWire

Avinger's (AVGR) CEO Jeff Soinski on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Is (AVGR) Outperforming Other Medical Stocks This Year?

1 year ago - Zacks Investment Research

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Is (AVGR) Outperforming Other Medical Stocks This Year?

2 years ago - Zacks Investment Research

Avinger (AVGR) closed at $0.58 in the latest trading session, marking a -0.62% move from the prior day.

2 years ago - Zacks Investment Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 9th.

Other stocks mentioned: ADP, CMG
2 years ago - Zacks Investment Research

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot fa... [Read more...]

Industry
Medical Devices
IPO Date
Jan 30, 2015
CEO
Jeffrey Soinski
Employees
69
Stock Exchange
NASDAQ
Ticker Symbol
AVGR
Full Company Profile

Financial Performance

In 2020, Avinger's revenue was $8.76 million, a decrease of -4.05% compared to the previous year's $9.13 million. Losses were -$19.01 million, -2.28% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for Avinger stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 176.55% from the latest price.

Price Target
$2.50
(176.55% upside)
Analyst Consensus: Buy